Portal de investigación
ESTUDIO RETROSPECTIVO MULTICÉNTRICO QUE ANALIZA LA EFICACIA Y SEGURIDAD DE LA PAUTA DOLUTEGRAVIR + RILPIVIRINA EN LA PRÁCTICA CLÍNICA HABITUAL. ESTUDIO DORIPLA.
Datos básicos
- Código:
- FSG-DOL-2019-01
- Protocolo:
- FSG-DOL-2019-01
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2019
- Año de finalización:
- 2020
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
A clinical predictive model of candidemia by Candida auris in previously colonised critically ill patients.
Garcia-Bustos V; (...); Pemán J
Article. 10.1016/j.cmi.2020.02.001. 2020
A NKp80-Based Identification Strategy Reveals that CD56 neg NK Cells Are Not Completely Dysfunctional in Health and Disease.
Orrantia A; (...); Borrego F
Article. 10.1016/j.isci.2020.101298. 2020
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Santos JR; (...); Paredes R
Article. 10.1093/ofid/ofad542. 2023
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimc.2021.05.009. 2021
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimce.2021.05.020. 2023
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C; (...); Garcia-Vidal, C
Article. 10.1093/jac/dkz491. 2020
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.
Tenorio CH; (...); Vallecillos CG
Article. 10.1016/j.ijantimicag.2024.107164. 2024
Biomarkers of fungal infection: Expert opinion on the current situation
Bouza, E; (...); Sanguinetti, M
Review. 10.37201/req/2260.2019. 2020
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rodriguez-Leal, Cristobal M.; (...); Salavert, Miguel
Review. 10.37201/req/018.2024. 2024
Candidemia in solid organ transplant recipients in Spain: epidemiological trends and determinants of outcome.
Fernández-Ruiz M; (...); Aguado JM
Article. 10.1111/tid.13195. 2019
Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort.
Hidalgo-Tenorio, Carmen; (...); Sadyrbaeva-Dolgova, Svetlana
Article. 10.3390/antibiotics12071218. 2023
Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia.
Ruiz J; (...); Ramirez P
Article. 10.1177/1559325819885790. 2020
Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach.
Garcia-Bustos, Victor; (...); Peman, Javier
Article. 10.1016/j.cmi.2023.03.016. 2023
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
Ferrer, Ricard; (...); McCann, Eilish
Article. 10.37201/req/096.2021. 2021
Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens.
Piñana JL; (...); Navarro D
Letter. 10.1016/j.jinf.2020.01.001. 2020
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007. 2023
CMV REACTIVATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FROM HLA-MATCHED AND HAPLOIDENTICAL DONORS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE.
Article. 10.1016/j.jtct.2024.01.082. 2024
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Babich, T; (...); Yahav, D
Article. 10.1093/jac/dkab134. 2021
Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
De La Puerta R; (...); Piñana JL
Article. 10.1038/s41409-021-01319-5. 2021
Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.
Montoro J; (...); Piñana JL
Article. 10.1038/s41409-020-0943-0. 2020
Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].
Monzó-Gallo P; (...); Garcia-Vidal C
Correction. 10.1016/j.ijid.2024.107188. 2024
CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT
Fragio-Gil, J. J.; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.
Fragío Gil JJ; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2020.08.007. 2022
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield
Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2020.08.002. 2022
Current approach to skin and soft tissue infections. Thinking about continuity of care.
Blanes Hernández R; (...); Salavert Lletí M
Article. 10.37201/req/s01.10.2023. 2023
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.
Garcia-Bustos, Victor; (...); Blanes, Marino
Article. 10.37201/req/s03.16.2022. 2022
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.
Vidal-Cortes, Pablo; (...); Zaragoza, Rafael
Review. 10.3390/antibiotics11091160. 2022
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1186/s13071-020-3901-1. 2020
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.
Puerta-Alcalde, Pedro; (...); Garcia-Vidal, Carolina
Article. 10.1093/mmy/myac038. 2022
Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; (...); Pemán J
Article. 10.1128/Spectrum.00013-21. 2021
Dalbavancin in clinical practice in Spain: a 2 year retrospective study.
Morata, Laura; (...); Almirante, Benito
Article. 10.1093/jacamr/dlac120. 2022
Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study.
Morata Ruiz L; (...); Grossi PA
Article. 10.1016/j.jgar.2023.11.015. 2024
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).
Podzamczer D; (...); Moreno S
Article. 10.1093/ofid/ofab595. 2022
Decalogue for the selection of oral antibiotics for lower respiratory tract infections
Canton, Rafael; (...); Gonzalez del Castillo, Juan
Article. 10.37201/req/172.2021. 2022
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimc.2020.05.021. 2021
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimce.2021.07.003. 2021
Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis.
Asensi Cantó P; (...); Guerreiro M
Article. 10.1111/tid.14067. 2023
Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
Garcia-Bustos, V; (...); Munoz, EC
Editorial Material. 10.3389/fcimb.2021.671962. 2021
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).
Hidalgo-Tenorio, Carmen; (...); Garcia-Vallecillos, Coral
Article. 10.3390/v14030524. 2022
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Troya, Jesus; (...); Buzon, Luis
Article. 10.1097/MD.0000000000029252. 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Babich T; (...); Yahav D
Article. 10.1007/s40121-022-00657-1. 2022
Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.
Perez Elias MJ; (...); Martinez E
Article. 10.1093/jac/dkaa547. 2021
Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
Cabanero-Navalon, Marta Dafne; (...); Carda-Dieguez, Miguel
Article. 10.1016/j.clim.2023.109796. 2023
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.
Gutierrez, Felix; (...); Masia, Mar
Article. 10.1093/cid/ciae359. 2024
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Moreno-Garcia, E; (...); Garcia-Vidal, C
Article. 10.1093/ofid/ofab250. 2021
Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study
Bouza, E; (...); Limon, E
Article. 10.37201/req/135.2020. 2021
Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients
Cordero, E; (...); Perez-Romero, P
Article. 10.3389/fimmu.2020.01917. 2020
Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
Corona, Diana; (...); Rivero, Antonio
Article. 10.1016/j.ijantimicag.2023.107016. 2024
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.
Santos JR; (...); Paredes R
Article. 10.3389/fcimb.2023.1187999. 2023
Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients
Suarez-Garcia, I.; (...); Jarrin, I.
Meeting Abstract. 2021
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.
Palacios, R.; (...); Santos, J.
Article. 10.1111/hiv.13489. 2023
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
Teira, R; (...); Espinosa, N
Article. 10.1080/25787489.2021.1955197. 2021
Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach.
Blanes Hernández R, Blanes Juliá M
Article. 10.37201/req/s01.01.2023. 2023
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C; (...); González Garcia J
Article. 10.1111/hiv.13229. 2022
Etiology, diagnosis, and management of pneumonia in immunosuppressed patients.
Salavert Lleti, Miguel; (...); Garcia-Bustos, Victor
Article. 10.37201/req/s01.20.2022. 2022
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
Ruiz-Rodriguez P; (...); Coscolla M
Article. 10.1128/mBio.02315-21. 2021
Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases.
Len O; (...); Domínguez-Gil B
Article. 10.1016/j.eimc.2019.10.016. 2019
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda
Article. 10.3390/v15071449. 2023
Factors associated with late presentation for HIV care in adolescents in Spain
Epalza, Cristina; (...); Luisa Navarro, Maria
Article. 10.1111/hiv.13407. 2022
Factors associated with sepsis development in 606 Spanish adult patients with cellulitis
Collazos, J; (...); Asensi, V
Article. 10.1186/s12879-020-4915-1. 2020
Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts
Bassetti M; (...); Munoz, P
Article. 10.1186/s13054-020-2793-y. 2020
Factors associated with the number of drugs in darunavir/cobicistat regimens.
Martinez E; (...); Perez-Elias MJ
Article. 10.1093/jac/dkz399. 2020
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study
Escudero-Sanchez, Rosa; (...); Cobo Reinoso, Javier
Article. 10.1093/jac/dkac106. 2022
Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J; (...); Quindós G
Review. 10.1016/j.riam.2020.07.001. 2020
Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies
Candel, FJ; (...); Peman, J
Review. 10.1016/j.riam.2019.09.001. 2020
Genomic characterization of Citrobacter freundii strains coproducing OXA-48 and VIM-1 carbapenemase enzymes isolated in leukemic patient in Spain
Lalaoui, R; (...); Rolain, JM
Article. 10.1186/s13756-019-0630-3. 2019
High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous $\beta$-Lactams.
Djukovic, Ana; (...); Ubeda, Carles
Article. 2020
High heterogeneity of multidrug-resistant Enterobacteriaceae fecal levels in hospitalized patients is partially driven by intravenous beta-lactams.
Djukovic A; (...); Ubeda C
Article. 10.1128/AAC.01415-19. 2020
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018
Perez-Latorre, L; (...); Gonzalez-Garcia, J
Article. 10.2807/1560-7917.ES.2021.26.25.2000236. 2021
Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella
Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo
Article. 10.1080/22221751.2021.2017756. 2022
How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations
Fernandez-Ruiz, Mario; (...); Aguado, Jose Maria
Article. 10.1016/j.eimc.2024.06.003. 2024
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.
Fernandez-Ruiz, Mario; (...); Abril, Vicente
Article. 10.1016/j.eimce.2024.07.001. 2024
How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort
Suarez-Garcia, I; (...); Hernando, V
Article. 10.1186/s12905-021-01370-w. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M; (...); Martínez E
Article. 10.1186/s13063-021-05777-6. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)
Masia, M.; (...); Martinez, E.
Correction. 10.1186/s13063-023-07655-9. 2023
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
Merchante, N; (...); Pineda, JA
Article. 10.1097/QAD.0000000000002578. 2020
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.
Mussini, Cristina; (...); van Wyk, Jean
Article. 10.1007/s10461-024-04490-0. 2024
Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.
Chorao, Pedro; (...); Sanz, Jaime
Article. 10.1016/j.jtct.2024.12.006. 2024
Intravenous Busulfan-Melphalan vs Melphalan as Preparative Regimen for Newly Diagnosed Multiple Myeloma: Long-Term Follow-Up of a Case-Control Study
Blanes, M; (...); de la Rubia, J
Meeting Abstract. 10.1016/j.clml.2019.09.473. 2019
Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015
Perez-Nadales, E; (...); Spanish Fusariosis Study Grp
Article. 10.3201/eid2701.190782. 2021
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Álvarez H; (...); Poveda E
Article. 10.3389/fimmu.2023.1257725. 2023
Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007_g. 2023
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain
Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez
Article. 10.1016/j.eimc.2023.07.005. 2024
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.
Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo
Article. 10.1016/j.eimce.2023.07.009. 2023
Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report
Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero
Editorial Material. 10.1016/j.eimc.2024.02.008. 2024
Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.
Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta
Case Reports. 10.1016/j.eimce.2024.04.004. 2024
Lack of evidence for infectious SARS-CoV-2 in feces and sewage
Albert, Sandra; (...); Domingo-Calap, Pilar
Article. 10.1007/s10096-021-04304-4. 2021
Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy
Vizcarra, P; (...); Moral, SD
Article. 10.1080/23744235.2019.1694696. 2020
Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.
Cabanero-Navalon MD; (...); Garcia-Bustos V
Article. 10.3390/biomedicines12102239. 2024
Long or complicated mpox in patients with uncontrolled HIV infection.
Corma-Gómez A; (...); Macías J
Article. 10.1002/jmv.29511. 2024
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.
Tarancon-Diez, Laura; (...); Muñoz-Fernández MÁ
Article. 10.1016/j.biopha.2023.114587. 2023
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Correction. 10.1016/j.kint.2024.10.002. 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Article. 10.1016/j.kint.2024.04.010. 2024
Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients
Casado, JL; (...); De Santiago, AD
Article. 10.1177/0956462419896478. 2020
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
Garcia-Broncano, P; (...); GESIDA 3603b Study Grp
Article. 10.1016/j.jinf.2019.09.020. 2020
Mitral repair results in endocarditis
Dominguez-Massa, C; (...); Montero-Argudo, JA
Article. 10.1016/j.circv.2020.08.005. 2020
Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.
Bernardino, Jose I.; (...); Rodes, Berta
Article. 10.3390/microorganisms11071818. 2023
Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain.
Berzosa Sánchez A; (...); Ramos Amador JT
Article. 10.1097/INF.0000000000003009. 2021
Mucormycosis: Current and future management perspective
Gomez, MTM, Lleti, MS
Article. 10.1016/j.riam.2021.04.003. 2021
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency.
Moral Moral, Pedro; (...); Salavert Lleti, Miguel
Article. 10.37201/req/s03.14.2022. 2022
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)
Perez Elias, MJ; (...); CODAR Study Grp
Article. 10.1093/jac/dkz254. 2019
Papel de cefditoreno en el tratamiento de las infecciones comunitarias de piel y tejidos blandos: revisando la evidencia.
Cabañero-Navalón MD, García-Bustos V, Salavert Lletí M
Review. 10.37201/req/063.2021. 2021
Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
Llibre, Josep M; (...); Alcantara, Felipe Rodriguez
Article. 10.1111/hiv.13650. 2024
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Casadellà M; (...); Noguera-Julian M
Article. 10.1093/jac/dkaa349. 2020
Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance.
Garcia-Bustos V; (...); Lletí MS
Article. 10.1038/s41598-021-90949-2. 2021
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).
Valencia ME; (...); González J
Article. 10.1016/j.eimce.2024.05.005. 2024
Psychological distress in women and men living with HIV in Spain: a cross-sectional telephone survey
Garriga, C; (...); Rodriguez-Arenas, MA
Article. 10.1136/ebmental-2019-300138. 2020
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.
Teira, Ramon; (...); Berenguer, Juan
Article. 10.1371/journal.pone.0249515. 2021
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.
Escudero-Sánchez R; (...); Cobo J
Article. 10.1007/s15010-020-01567-5. 2021
Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015
Gonzalez, J; (...); Cohort Spanish HIV Res Network Co
Article. 10.1016/j.eimc.2019.02.007. 2019
Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.
Hernando V; (...); CoRIS-HIV Biobank
Article. 10.1080/23744235.2021.1893377. 2021
Recomendaciones GEMICOMED/GEIRAS-SEIMC para el manejo de las infecciones y colonizaciones por Candida auris.
Alastruey-Izquierdo A; (...); en nombre de GEMICOMED GEIRAS-SEIMC
Abstract of Published Item. 10.1016/j.riam.2019.06.001. 2019
Recommendations for antibiotic selection for severe nosocomial infections
Mensa, Josep; (...); Soriano, Alex
Article. 10.37201/req/126.2021. 2021
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
Los-Arcos I; (...); Ruiz-Camps I
Review. 10.1007/s15010-020-01521-5. 2020
Recommendations on the use of azole antifungals in hematology-oncology patients
Azanza, Jose Ramon; (...); Gutierrez, Carlos Duenas
Review. 10.37201/req/013.2023. 2023
Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies
Javier Candel, Francisco; (...); Cuervo Pinto, Rafael
Review. 10.37201/req/023.2023. 2023
Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
Carrasco, I; (...); Navarro, ML
Article. 10.1111/jvh.13308. 2020
Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review.
Garcillan, Beatriz; (...); Diaz-Castroverde, Sabela
Article. 10.3390/vaccines10020297. 2022
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study.
Babich T; (...); Yahav D
Article. 10.1016/j.ijantimicag.2019.11.004. 2020
Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study
Salto-Alejandre, S; (...); Cordero, E
Article. 10.1371/journal.pone.0250796. 2021
Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin.
Merchante, Nicolas; (...); Merino, Esperanza
Article. 10.1093/jacamr/dlad033. 2023
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.
Monzo-Gallo, Patricia; (...); Garcia-Vidal, Carolina
Article. 10.1016/j.ijid.2024.107070. 2024
Safety and Tolerability of More than Six Days of Tedizolid Treatment
Vendrell, MM; (...); Viladomiu, AS
Article. 10.1128/AAC.00356-20. 2020
Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.
Len O; (...); Domínguez-Gil B
Review. 10.1016/j.trre.2020.100528. 2020
Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study.
Collazos J; (...); Asensi V
Article. 10.1016/j.ijid.2021.01.044. 2021
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Teira, Ramon; (...); Curran, Adria
Article. 10.1007/s40121-022-00630-y. 2022
Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR)
Bouza, Emilio; (...); Barberan, Jose
Article. 10.37201/req/2065.2020. 2020
Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis
Podzamczer, D.; (...); Rivero, A.
Meeting Abstract. 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer, Daniel; (...); Rivero, Antonio
Article. 10.1093/jac/dkad285. 2023
Tedizolid: new data and experiences for clinical practice.
Salavert Lleti, M; (...); Cabanero-Navalon, M D
Article. 10.37201/req/s01.06.2021. 2021
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Serrano, Leyre
Article. 10.3390/jcm12216864. 2023
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.3390/jcm12206526. 2023
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations.
Guerrero-Beltrán C; (...); Moreno S
Article. 10.1093/jac/dkaa009. 2020
The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.
Piñana J; (...); Sanz J
Article. 10.1016/j.jinf.2019.12.022. 2020
The Challenge of Treating Infections Caused by Metallo-ß-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
Hidalgo-Tenorio C; (...); Martínez-Martínez L
Article. 10.1007/s40265-024-02102-8. 2024
The positioning of ceftobiprole in Staphylococcus aureus bacteremia.
Membrillo de Novales FJ; (...); Hidalgo-Tenorio C
Article. 10.1093/cid/ciae123. 2024
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.1186/s13054-024-05224-3. 2024
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
Alonso-Navarro, Rodrigo; (...); Soriano, Alex
Article. 10.1186/s12879-023-08222-y. 2023
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Vinuela, Laura; (...); Garcia, Federico
Article. 10.1002/jmv.29287. 2023
Tratamiento y prevención de la viruela del mono.
de la Calle-Prieto F; (...); Membrillo FJ
Article. 10.1016/j.eimc.2022.08.001. 2022
Treatment and prevention of monkeypox
Calle-Prieto, Fernando de la; (...); , TERDDPUGDDIYGDDDDS
Review. 10.1016/j.eimc.2022.08.0010213-005X. 2023
Treatment and prevention of monkeypox.
de la Calle-Prieto, Fernando; (...); Membrillo, Francisco Javier
Article. 10.1016/j.eimce.2022.12.010. 2023
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
Ruiz-Alguero, Marta; (...); Jarrin, Inma
Article. 10.1111/hiv.13469. 2023
Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients
Gil, JJF; (...); Ivorra, JAR
Article. 10.1016/j.medcli.2019.12.029. 2020
What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.
Garcia-Bustos V; (...); Pemán J
Article. 10.3390/microorganisms9102177. 2021
Whether to make decisions "on the fly" regarding treatment for SARS-CoV-2 infection
de Medrano, VAL, de Lucas, EM, Lleti, MS
Letter. 10.1016/j.rce.2020.04.004. 2020